Updated Jul 16, 2026
Harmon Seth is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Seth Harmon is associated with Viridian Therapeutics, Inc., a biotechnology company focused on developing therapies for patients with serious diseases. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-09 | VRDN | Viridian Therapeutics, Inc.\DE | F — Tax withholding / forfeiture | 2.0K | $30.19 | $61K |
| 2026-03-05 | VRDN | Viridian Therapeutics, Inc.\DE | F — Tax withholding / forfeiture | 2.1K | $29.32 | $61K |
| 2026-03-05 | VRDN | Viridian Therapeutics, Inc.\DE | M — Option exercise | 6.3K | — |
Seth Harmon is associated with Viridian Therapeutics, Inc., a biotechnology company focused on developing therapies for patients with serious diseases. Specific details about his role and contributions to the company are not widely documented.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Harmon Seth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.